Work

The Development and Current Use of BCL-2 Inhibitors for the Treatment of Chronic Lymphocytic Leukemia

Year: 2017

Type: review

Source: Current Hematologic Malignancy Reports

DOI: 10.1007/s11899-017-0359-0

Authors: Benjamin L. Lampson, Matthew S. Davids

Institutions: Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Award: Physician Scientist Training in Cancer Research

OpenAlex ID: W2582864842

FWCI: 0.777

Cites: 58

Cited by: 54

Related to: 10